About Strateos
Strateos is a company based in Menlo Park (United States) founded in 2019. Strateos has raised $72.6 million across 3 funding rounds from investors including Lilly, HHS and DCVC. The company has 147 employees as of December 31, 2021. Strateos offers products and services including Cloud Lab, AI for Drug Discovery, Assay Onboarding and Development, and High Content Imaging. Strateos operates in a competitive market with competitors including Veeva Systems, Dotmatics, Sygnature Discovery, Instem and Molecular Connections, among others.
- Headquarter Menlo Park, United States
- Employees 147 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Strateos, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$72.6 M (USD)
in 3 rounds
-
Latest Funding Round
$56.1 M (USD), Series B
Jun 08, 2021
-
Investors
Lilly
& 7 more
-
Employee Count
147
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Strateos
Strateos offers a comprehensive portfolio of products and services, including Cloud Lab, AI for Drug Discovery, Assay Onboarding and Development, and High Content Imaging.
Platform for remote control of scientific experiments and workflows.
Tools to accelerate drug discovery through automated data analysis.
Services for developing and optimizing assays in high-throughput settings.
System for advanced imaging in tissue and synthetic biology applications.
People of Strateos
Unlock access to complete
Unlock access to complete
Funding Insights of Strateos
Strateos has successfully raised a total of $72.6M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $56.1 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Strateos
Strateos has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Lilly, HHS and DCVC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Seed and early-stage technology companies are funded by Lux Capital.
|
Locked | Locked | Locked | |
|
Private equity and hedge fund investments in healthcare are managed.
|
Locked | Locked | Locked |
Investor details for Strateos
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Strateos
Investment portfolio details for Strateos
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Strateos
Detailed financials for Strateos
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Strateos Comparisons
Peer comparison for Strateos
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Strateos
Strateos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Veeva Systems, Dotmatics, Sygnature Discovery, Instem and Molecular Connections, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based data management solutions for healthcare are provided.
|
|
| Locked | Locked | Locked |
AI powered scientific data management and workflow automation solutions
|
|
| Locked | Locked | Locked |
Services and products for integrated drug discovery are provided.
|
|
| Locked | Locked | Locked |
Software for life science data collection and analysis is provided.
|
|
| Locked | Locked | Locked |
Databases and analytics for drug discovery are provided.
|
Detailed competitors of Strateos
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Strateos
Complete news archive for Strateos
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Strateos
Strateos was founded in 2019.
Strateos is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
David Lynch is the current CEO of Strateos.
Strateos is a funded company, having raised a total of $72.6M across 3 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Strateos is 147.
Provider of the cloud-based platform provides data-driven information for biotech research. It offers a cloud-based platform that provides data-driven information for biotech research. The platform helps in drug discovery and synthetic biology research. Its solutions include robotic cloud lab, scale on-site, and on-demand discovery biology among others.
Strateos's top competitors include Veeva Systems, Dotmatics and Sygnature Discovery.
Strateos offers Cloud Lab, AI for Drug Discovery, Assay Onboarding and Development, and High Content Imaging.
Strateos has 8 investors. Key investors include Lilly, HHS, DCVC, Lux Capital, and Ally Bridge Group.